Financial Times Feature: Big pharma takes a gamble on NHS experiment

Connected Healthcare

Look out for a full-page article featuring Health Innovation Manchester’s work with pharmaceutical companies in today’s edition of the Financial Times (Wednesday 28 August, Page 9).

The in-depth article explores how GlaxoSmithKline and other pharma companies are working with Manchester’s health system, marking an ambitious endeavour to improve the health of Greater Manchester’s population.

The article states: “Manchester offers a template for radical changes, both in how patients are treated and how quickly new drugs are adopted by cash-strapped health providers.

“Unique in its scope and scale, it is attracting attention around the world.”

The Financial Times “Big Read” piece also includes interviews with Health Innovation Manchester’s Commercial Director Arjun Sikand, Associate Director Jay Hamilton, Respiratory consultant and COPD Clinical Lead Dr Binita Kane and Jon Rouse, Chief Officer of the Greater Manchester Health and Social Care Partnership as well as industry partners GSK and Janssen.

To read the article in full click here

Back to top